Aysel Fisgin

Medicine & Life Sciences

1. Peripheral Nervous System Diseases 100%
2. Axons 45%
3. Drug Therapy 44%
4. Ethoxyquin 39%
5. Fluocinolone Acetonide 35%
6. Paclitaxel 27%
7. Peripheral Nerve Injuries 27%
8. Calpain 26%
9. Bortezomib 26%
10. Vincristine 23%
11. Rodentia 22%
12. Upper Extremity 19%
13. Cisplatin 19%
14. DNA Adducts 18%
15. Wallerian Degeneration 16%
16. Stem Cells 15%
17. Nerve Fibers 15%
18. Platinum 15%
19. Neurons 14%
20. NAD 14%
21. Muscles 13%
22. Preclinical Drug Evaluations 12%
23. Blood Vessels 12%
24. 2,2,4-trimethyl-1,2-dihydroquinoline 12%
25. Peripheral Nerves 11%
26. Spinal Ganglia 11%
27. Pharmaceutical Preparations 11%
28. Myelin Sheath 11%
29. Pathologic Processes 11%
30. calpain inhibitors 10%
31. Neoplasms 9%
32. In Vitro Techniques 9%
33. Differential Diagnosis 8%
34. Nicotinamide Mononucleotide 7%
35. HSP90 Heat-Shock Proteins 7%
36. Therapeutics 6%
37. Pathology 6%
38. Schwann Cells 6%
39. Wounds and Injuries 6%
40. Sensory Receptor Cells 5%
41. Neuroprotection 5%
42. Biomarkers 5%
43. Neuroprotective Agents 5%